Nurse Practitioner, Family · Henderson, NV
NPI
1972211050
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2839 Saint Rose Pkwy Ste 130
Henderson, NV, 89052
Phone (702) 558-4027
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
305 services
Medicare patients, 2024
210
Average age 73
Drug cost, 2024
$495K
623 prescriptions
Company payments, 2025
$4,540
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reiko K Tapia was code 99213 (office e&m - established), 141 times for 107 patients. In total Reiko K Tapia billed 305 services in 4 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 141 | 107 | $53.58 | $7,555 |
| 99214 Office E&M - Established | Office | 103 | 90 | $75.81 | $7,809 |
| 99204 Office E&M - New | Office | 60 | 60 | $101.87 | $6,112 |
By year: 2023 $20K for 223 services; 2024 $22K for 305 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reiko K Tapia prescribed most often to Medicare patients was Pantoprazole Sodium, with 197 prescriptions and refills. In total Reiko K Tapia wrote 623 Medicare prescriptions that cost $495K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 197 | 567 | 110 | $1,660 |
| Famotidine Generic | 68 | 185 | 33 | $808 |
| Omeprazole Generic | 57 | 159 | 28 | $651 |
| Dicyclomine Hcl Generic | 47 | 113 | 28 | $2,213 |
| Cholestyramine Cholestyramine (With Sugar) | 37 | 54 | 20 | $3,999 |
| Glycopyrrolate Generic | 36 | 69 | 11 | $107K |
| Sucralfate Generic | 21 | 53 | 12 | $1,122 |
| Linzess Linaclotide | 15 | 35 | 11 | $18K |
| Spironolactone Generic | 14 | 40 | Under 11 | $436 |
| Lactulose Generic | 12 | 15 | Under 11 | $251 |
| Epclusa Sofosbuvir/Velpatasvir | 11 | 11 | Under 11 | $263K |
Brand drugs: 66 claims; generic drugs: 557 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reiko K Tapia $4,540 ($4,540 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $872.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $872 |
| Janssen Biotech, Inc. JNJ | 26 | $703 |
| Intra-Sana Laboratories | 39 | $508 |
| Gilead Sciences, Inc. GILD | 19 | $501 |
| Phathom Pharmaceuticals, Inc. PHAT | 11 | $365 |
| Madrigal Pharmaceuticals MDGL | 8 | $363 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $281 |
| Genzyme Corporation SNY | 15 | $190 |
| Aimmune Therapeutics, Inc. | 4 | $182 |
| Novo Nordisk Inc NVO | 5 | $171 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.